Stock Comparison
EXEL vs VRTX
Exelixis Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$12.80B
$123.94B
P/E (TTM)
16.3
28.5
Forward P/E
16.3
25.7
Price/Sales
5.3
9.9
Price/Book
7.0
6.1
EV/EBITDA
11.9
23.2
Dividend Yield
—
—
Profitability
Net Margin
35.33%
35.40%
Operating Margin
39.88%
38.97%
Return on Equity
44.40%
23.50%
Return on Assets
24.00%
11.90%
Growth (YoY)
Revenue Growth
10.60%
12.50%
Earnings Growth
26.20%
8.00%
Price & Risk
Beta
0.4
0.3
52-Week High
$57.10
$529.65
52-Week Low
$34.54
$376.62
Analyst Target
$52.88
$559.28
Compare EXEL and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.